Jove
Visualize
Contact Us

Related Concept Videos

Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

3.1K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
3.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

9.6K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
9.6K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

651
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
651

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Turning over renal osteodystrophy dogma: direct actions of FGF23 on osteoblast β-catenin pathway.

Kidney international·2016
Same author

Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.

Science translational medicine·2015
Same author

Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.

Seminars in dialysis·2015
Same author

Role of NPT2b in health and chronic kidney disease.

Current opinion in nephrology and hypertension·2014
Same author

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2013
Same author

Npt2b deletion attenuates hyperphosphatemia associated with CKD.

Journal of the American Society of Nephrology : JASN·2012
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 17, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.7K

Sclerostin and CKD-MBD.

Susan C Schiavi1

  • 1Genzyme, Boston, MA, USA, scschiavi@gmail.com.

Current Osteoporosis Reports
|February 19, 2015
PubMed
Summary
This summary is machine-generated.

Declining kidney function alters mineral balance, affecting bones and the cardiovascular system. Elevated sclerostin, a protein linked to kidney disease, impacts bone health and may influence cardiovascular calcification.

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.7K

Related Experiment Videos

Last Updated: Apr 17, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.7K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.7K

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Biology

Background:

  • Chronic kidney disease (CKD) disrupts mineral homeostasis, leading to skeletal and cardiovascular complications.
  • Osteocyte-derived sclerostin increases with renal injury, inhibiting bone formation via Wnt/β-catenin signaling.
  • The role of Wnt/β-catenin signaling in CKD-mineral and bone disorder (CKD-MBD) is complex, with potential dual effects on bone and vasculature.

Purpose of the Study:

  • To explore the role of sclerostin and Wnt/β-catenin signaling in the systemic changes associated with declining kidney function.
  • To understand the differential skeletal effects of agents targeting β-catenin signaling in the context of CKD.
  • To investigate the relationship between circulating sclerostin levels and cardiovascular disease progression in CKD patients.

Main Methods:

  • Review of current literature on sclerostin, Wnt/β-catenin signaling, and CKD-MBD.
  • Analysis of existing epidemiological data on sclerostin and cardiovascular outcomes in CKD.
  • Discussion of the molecular mechanisms linking renal function, bone metabolism, and vascular health.

Main Results:

  • Elevated sclerostin is an early indicator of renal injury, correlating with reduced bone formation.
  • Wnt/β-catenin signaling inhibition by sclerostin contributes to diverse forms of renal osteodystrophy.
  • Emerging data suggests Wnt/β-catenin signaling may have protective roles in cardiovascular health despite its role in calcification.

Conclusions:

  • Sclerostin and Wnt/β-catenin signaling are critical mediators in CKD-MBD, influencing both skeletal and cardiovascular health.
  • Further epidemiological studies are needed to elucidate the precise role of sclerostin in CKD progression and cardiovascular disease.
  • Understanding these pathways is crucial for developing targeted therapies for CKD complications.